As federal research priorities expand to close critical gaps in women’s health, MIT biological engineering provides the tools, models, and vision to meet the moment.
A new White House Executive Order signed on October 19 establishes a dedicated Women’s Health Division at the National Institutes of Health (NIH) and creates a White House Women’s Health Task Force. The directive represents a long-overdue mandate to close persistent gaps in scientific understanding and direct federal resources toward conditions that disproportionately affect women and girls.
Melania Trump, who championed the directive, outlined five priorities in her remarks at the signing ceremony:
- Directing research funding toward cures for conditions disproportionately affecting women.
- Using artificial intelligence to accelerate medical discoveries.
- Accelerating the development of targeted therapeutics for women.
- Delivering medical breakthroughs at an affordable price.
- Dismantling historic taboos around women’s health conversations.
Center for Gynepathology Research (CGR) Director Linda Griffith was invited to attend the Rose Garden signing ceremony in recognition of MIT’s leadership in elevating gynecology and sex-based immune disorders into top-tier biomedical research areas. For Griffith, a bioengineering pioneer known for her work on 3D printing (3DP™) for tissue scaffolds and pioneering complex organ models, the policy validates a core premise: female reproductive biology is not a niche medical specialty. It is a complex systems challenge requiring advanced engineering to untangle how sex-based biology shapes immunity, disease, and health outcomes.
“This initiative has enormous potential to help women. As CGR Director, I have been involved in discussions at NIH over many years on how to bridge NIH Institutes and Centers to address the systemic, whole-body effects of diseases that preferentially afflict women,” Griffith said. “In the context of our new NIH-funded NAMs Technology Development Center for Women’s Health and other efforts, including the Menstruation Science Initiative, I expect CGR to contribute substantially to this new effort. Women’s health is a quintessential engineering problem. We need a real vibe shift across biomedical research, and MIT technology and engineering systems analysis can help drive that change.”
Historically, progress in conditions such as endometriosis and adenomyosis has been hampered because traditional animal models fail to reflect human female biology. Founded at MIT in 2009 by Griffith and Keith Isaacson, CGR is now led by Griffith with clinical co-director Peter Movilla.
The Center bridges more than 15 Boston-area research laboratories and clinical practices to engineer human-relevant Novel Alternative Methodologies (NAMs). This broad toolkit includes microphysiological systems (MPS) such as organ-on-a-chip technologies, and lab-grown human tissue models that allow researchers to capture patient-specific pathology, interrogate disease mechanisms, and test targeted therapeutics with greater precision.
While federal priorities highlight the role of artificial intelligence and advanced computing to speed discovery, computational models remain only as reliable as their input data. In women’s health, historic underfunding means baseline data is often missing or sparse, risking misleading algorithmic conclusions. CGR’s approach applies rigorous engineering analysis first: defining what biological signals must be measured, determining how to measure them, and inventing new measurement tools when existing methods fall short.
This technical pipeline relies on close partnerships with clinicians, epidemiologists, and geneticists to phenotype patients into meaningful subpopulations. Systems biology analysis of well-phenotyped patients is just as vital as the engineered models themselves; together, they anchor the NAMs ecosystem and CGR’s mission.
The new Executive Order provides critical momentum for CGR and the NIH-funded NAMs Center at MIT as federal priorities align with high-impact translational science to transform health care for women and girls everywhere.
